HNORY (Harvey Norman Holdings) Research & Development: $0 Mil (TTM As of Dec. 2025)


HNORY Harvey Norman Holdings Ltd HNORY
72 GF Score
Price $15.62
GF Value $10.78
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Harvey Norman Holdings Research & Development?

Harvey Norman Holdings HNORY 72 Research & Development is $0 Mil as of Dec. 2025. GuruFocus rates HNORY with a GF Score™ of 72/100 and a GF Value™ of $10.78 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Harvey Norman Holdings's Research & Development for the six months ended in Dec. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

Harvey Norman Holdings  (OTCPK:HNORY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Harvey Norman Holdings Research & Development Related Terms

Harvey Norman Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Harvey Norman Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harvey Norman Holdings Research & Development Chart

Harvey Norman Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Harvey Norman Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HNORY
72GF Score
Harvey Norman Holdings Ltd HNORY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harvey Norman Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Harvey Norman Holdings (HNORY) has a Research & Development of $0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Harvey Norman Holdings and its competitors.
Is Harvey Norman Holdings' Research & Development too high?
Harvey Norman Holdings' current Research & Development is $0 Mil. Overall, Harvey Norman Holdings has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Harvey Norman Holdings' Research & Development compare to CASY and WSM?
Harvey Norman Holdings' Research & Development of $0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Cyclical company?
A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Harvey Norman Holdings and its competitors. Harvey Norman Holdings's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvey Norman Holdings stock overvalued right now?
Based on GuruFocus' analysis, Harvey Norman Holdings (HNORY) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.78, compared to a current price of $15.62 — trading 44.9% above its estimated fair value. The current Research & Development is $0 Mil. Harvey Norman Holdings' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Harvey Norman Holdings (HNORY), the current Research & Development is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harvey Norman Holdings (HNORY) Overvalued in 2026?

Based on GuruFocus' analysis, Harvey Norman Holdings stock appears to be overvalued. The current stock price of $15.62 is trading 44.9% above its estimated GF Value™ of $10.78. GuruFocus considers Harvey Norman Holdings to be Significantly Overvalued.

Key valuation signals for HNORY:

  • Research & Development: $0 Mil
  • GF Value™: $10.78 vs. price of $15.62 (44.9% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the HNORY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Harvey Norman Holdings Business Description

Address A1 Richmond Road, Homebush West, Sydney, NSW, AUS, 2140
Harvey Norman Holdings Limited is the franchisor of Harvey Norman, a leading Australia-based retailer that sells goods from the electrical, computer, furniture, entertainment, and bedding sectors. The majority of earnings are generated in Australia, with the international divisions gradually growing in significance.
72GF Score

Get the complete analysis for HNORY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.62
Price
$10.78
GF Value